交易 Ligand Pharmaceuticals Incorpor - LGND CFD
新增到我的最愛- 摘要
- 曆史數據
- 活動
- 盈虧控制
- 資産負債表
- 現金流
交易條件
價差 | 0.58 | ||||||||
多頭倉位隔夜費用
多頭隔夜費用
前往平台 | -0.026179% | ||||||||
空頭倉位隔夜費用
空頭隔夜費用
前往平台 | 0.003957% | ||||||||
隔夜費時間 | 21:00 (UTC) | ||||||||
最小成交量 | 1 | ||||||||
貨幣 | USD | ||||||||
保證金 | 5% | ||||||||
股票交易 | United States of America | ||||||||
交易委員會 | 0% |
*Information provided by Capital.com
Ligand Pharmaceuticals Inc ESG Risk Ratings
High Medium Low Negligible
“C”分數表示在公開報告重大 ESG 數據方面令人滿意的相對 ESG 表現和適度的透明度。
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 拋售 | 自訂 | 變化 (%) | 打開 | 最高 | 最小 |
---|---|---|---|---|---|---|
Apr 18, 2024 | 72.45 | -5.19 | -6.68% | 77.64 | 77.94 | 72.26 |
Apr 17, 2024 | 78.43 | -0.27 | -0.34% | 78.70 | 80.15 | 77.71 |
Apr 16, 2024 | 79.25 | 1.21 | 1.55% | 78.04 | 81.20 | 78.04 |
Apr 15, 2024 | 79.53 | 0.44 | 0.56% | 79.09 | 80.66 | 78.52 |
Apr 12, 2024 | 81.23 | 0.83 | 1.03% | 80.40 | 81.41 | 79.64 |
Apr 11, 2024 | 81.32 | 1.04 | 1.30% | 80.28 | 81.33 | 79.96 |
Apr 10, 2024 | 80.64 | 1.45 | 1.83% | 79.19 | 80.85 | 78.27 |
Apr 9, 2024 | 81.43 | 4.21 | 5.45% | 77.22 | 81.46 | 77.22 |
Apr 8, 2024 | 76.51 | -1.01 | -1.30% | 77.52 | 79.95 | 76.51 |
Apr 5, 2024 | 77.78 | 1.47 | 1.93% | 76.31 | 78.06 | 75.43 |
Apr 4, 2024 | 77.82 | -0.09 | -0.12% | 77.91 | 78.50 | 76.32 |
Apr 3, 2024 | 74.54 | 3.18 | 4.46% | 71.36 | 74.76 | 70.96 |
Apr 2, 2024 | 72.69 | 0.62 | 0.86% | 72.07 | 73.17 | 71.65 |
Apr 1, 2024 | 73.45 | 1.79 | 2.50% | 71.66 | 73.49 | 70.85 |
Mar 28, 2024 | 72.46 | 1.63 | 2.30% | 70.83 | 72.98 | 70.55 |
Mar 27, 2024 | 71.21 | 4.15 | 6.19% | 67.06 | 71.66 | 67.05 |
Mar 26, 2024 | 68.37 | -0.22 | -0.32% | 68.59 | 69.81 | 67.90 |
Mar 25, 2024 | 68.73 | -2.20 | -3.10% | 70.93 | 71.23 | 68.57 |
Mar 22, 2024 | 70.64 | -1.10 | -1.53% | 71.74 | 72.35 | 70.64 |
Mar 21, 2024 | 72.76 | 0.74 | 1.03% | 72.02 | 73.46 | 71.80 |
Ligand Pharmaceuticals Incorpor Events
時間 (UTC) | 國家 | 事件 |
---|---|---|
Thursday, May 2, 2024 | ||
時間 (UTC) 20:00 | 國家 US
| 事件 Q1 2024 Ligand Pharmaceuticals Inc Earnings Release Q1 2024 Ligand Pharmaceuticals Inc Earnings ReleaseForecast(預報) -返回 - |
Friday, June 7, 2024 | ||
時間 (UTC) 15:30 | 國家 US
| 事件 Ligand Pharmaceuticals Inc Annual Shareholders Meeting Ligand Pharmaceuticals Inc Annual Shareholders MeetingForecast(預報) -返回 - |
Tuesday, August 6, 2024 | ||
時間 (UTC) 10:59 | 國家 US
| 事件 Q2 2024 Ligand Pharmaceuticals Inc Earnings Release Q2 2024 Ligand Pharmaceuticals Inc Earnings ReleaseForecast(預報) -返回 - |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
總收入 | 196.245 | 277.133 | 186.419 | 120.282 | 251.453 |
收入 | 196.245 | 277.133 | 186.419 | 120.282 | 251.453 |
收入成本,共計 | 52.827 | 62.176 | 30.419 | 11.347 | 6.337 |
毛利 | 143.418 | 214.957 | 156 | 108.935 | 245.116 |
總營業費用 | 189.008 | 205.538 | 160.574 | -686.794 | 87.726 |
銷售/一般/行政費用,總計 | 70.062 | 57.483 | 64.435 | 41.884 | 37.734 |
研究與開發 | 36.082 | 69.012 | 59.392 | 55.908 | 27.863 |
Depreciation / Amortization | 34.237 | 47.167 | 23.442 | 16.864 | 15.792 |
異常費用(收入) | -4.2 | 7.3 | -17.114 | -812.797 | |
營業收入 | 7.237 | 71.595 | 25.845 | 807.076 | 163.727 |
利息收入(費用),非經營淨值 | 28.787 | -22.737 | -36.275 | -4.427 | 15.91 |
其他,淨值 | -0.013 | -1.56 | -0.108 | -6.01 | -6.307 |
稅前淨收入 | 36.011 | 47.298 | -10.538 | 796.639 | 173.33 |
稅後淨收入 | -5.219 | 57.138 | -2.985 | 629.302 | 143.921 |
少數股東權益 | |||||
未計算非常項目前的淨收益 | -5.219 | 57.138 | -2.985 | 629.302 | 143.921 |
非常規項目總計 | -28.142 | -0.6 | |||
淨收入 | -33.361 | 57.138 | -2.985 | 629.302 | 143.321 |
普通股股東可獲收益 (不含非經常性項目) | -5.219 | 57.138 | -2.985 | 629.302 | 143.921 |
普通股股東可獲收益 (含非經常性項目) | -33.361 | 57.138 | -2.985 | 629.302 | 143.321 |
攤薄淨收入 | -33.361 | 57.138 | -2.985 | 629.302 | 143.321 |
攤薄後加權平均股 | 16.868 | 17.246 | 16.185 | 19.757 | 24.067 |
扣除特別項目的每股攤薄盈利 | -0.3094 | 3.31312 | -0.18443 | 31.8521 | 5.98001 |
每股正常攤薄盈利 | -0.47125 | 3.58825 | -0.04041 | 5.1113 | 5.98001 |
Other Operating Expenses, Total | 0 | -37.6 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
總收入 | 26.366 | 43.979 | 27.045 | 66.088 | 57.419 |
收入 | 26.366 | 43.979 | 27.045 | 66.088 | 57.419 |
收入成本,共計 | 1.669 | 3.717 | 21.614 | 14.153 | 12.361 |
毛利 | 24.697 | 40.262 | 5.431 | 51.935 | 45.058 |
總營業費用 | 28.349 | 28.074 | 14.869 | 64.552 | 56.088 |
銷售/一般/行政費用,總計 | 11.287 | 10.855 | 19.852 | 17.445 | 14.585 |
研究與開發 | 6.854 | 6.663 | -3.549 | 22.036 | 19.118 |
Depreciation / Amortization | 8.539 | 8.539 | 11.818 | 11.824 | |
異常費用(收入) | 0 | -1.7 | 0 | -0.9 | -1.8 |
營業收入 | -1.983 | 15.905 | 12.176 | 1.536 | 1.331 |
利息收入(費用),非經營淨值 | 6.027 | 40.728 | 45.032 | -0.664 | -2.049 |
其他,淨值 | -0.873 | -1.097 | -1.278 | -0.015 | 0.082 |
稅前淨收入 | 3.171 | 55.536 | 55.93 | 0.857 | -0.636 |
稅後淨收入 | 2.29 | 43.614 | 10.657 | 0.404 | -0.895 |
未計算非常項目前的淨收益 | 2.29 | 43.614 | 10.657 | 0.404 | -0.895 |
淨收入 | 2.29 | 41.949 | -17.485 | 0.404 | -0.895 |
普通股股東可獲收益 (不含非經常性項目) | 2.29 | 43.614 | 10.657 | 0.404 | -0.895 |
普通股股東可獲收益 (含非經常性項目) | 2.29 | 41.949 | -17.485 | 0.404 | -0.895 |
攤薄淨收入 | 2.29 | 41.949 | -17.485 | 0.404 | -0.895 |
攤薄後加權平均股 | 17.73 | 17.974 | 16.892 | 17.132 | 16.868 |
扣除特別項目的每股攤薄盈利 | 0.12916 | 2.4265 | 0.63089 | 0.02358 | -0.05306 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常攤薄盈利 | 0.12916 | 2.35223 | 0.63089 | -0.01057 | -0.12242 |
Other Operating Expenses, Total | -23.048 | 0 | 0 | ||
非常規項目總計 | 0 | -1.665 | -28.142 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流動資産總額 | 263.601 | 464.751 | 500.559 | 1123.65 | 870.54 |
現金和短期投資 | 211.87 | 341.108 | 411.186 | 1069.87 | 773.829 |
現金等價物 | 45.006 | 19.522 | 47.619 | 71.543 | 117.164 |
短期投資 | 166.864 | 321.586 | 363.567 | 998.324 | 656.665 |
應收賬款總額,淨額 | 35.038 | 91.646 | 59.064 | 41.748 | 64.395 |
應收賬款 - 貿易,淨額 | 30.424 | 85.453 | 56.847 | 30.387 | 55.85 |
總庫存 | 13.294 | 27.326 | 26.487 | 7.296 | 7.124 |
預付的費用 | |||||
總資産 | 762.668 | 1297.59 | 1362.29 | 1494.92 | 1260.8 |
物業/廠房/設備,總計 - 淨額 | 27.491 | 53.26 | 37.168 | 17.538 | 5.372 |
物業/廠房/設備,總計 - 總額 | 37.616 | 61.971 | 41.975 | 20.388 | 7.537 |
累計折舊,總計 | -10.125 | -8.711 | -4.807 | -2.85 | -2.165 |
商譽,淨額 | 105.673 | 181.206 | 189.662 | 95.229 | 86.646 |
無形資産,淨額 | 352.637 | 561.15 | 606.309 | 230.538 | 251.253 |
長期投資 | 0 | ||||
其他長期資産,總計 | 13.266 | 37.223 | 28.587 | 27.965 | 46.992 |
流動負債總額 | 98.81 | 41.665 | 100.111 | 17.002 | 82.249 |
應付賬款 | 5.307 | 8.403 | 3.784 | 2.42 | 4.183 |
預提費用 | 16.351 | 19.632 | 20.415 | 9.836 | 19.2 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
長期債務的當前部分/資本租賃 | 76.74 | 0.046 | 6.593 | 0 | 26.433 |
其他流動負債,總計 | 0.412 | 13.584 | 69.319 | 4.746 | 32.433 |
負債總額 | 165.183 | 476.431 | 652.76 | 727.683 | 699.889 |
長期債務總額 | 0 | 320.717 | 442.293 | 638.959 | 609.864 |
長期債務 | 0 | 320.717 | 442.293 | 638.959 | 609.864 |
其他負債,總計 | 35.758 | 54.954 | 45.758 | 38.785 | 7.776 |
股權 | 597.485 | 821.159 | 709.525 | 767.232 | 560.914 |
普通股 | 0.017 | 0.017 | 0.016 | 0.017 | 0.021 |
額外實收資本 | 147.59 | 372.969 | 318.358 | 367.326 | 791.114 |
留存收益(累計赤字) | 450.862 | 449.09 | 391.952 | 400.105 | -229.197 |
其他權益,總計 | -0.984 | -0.917 | -0.801 | -0.216 | -1.024 |
總負債和股東權益 | 762.668 | 1297.59 | 1362.29 | 1494.92 | 1260.8 |
已發行普通股總數 | 16.951 | 16.767 | 16.08 | 16.823 | 20.7655 |
其他流動資産,總計 | 3.399 | 4.671 | 3.822 | 4.734 | 25.192 |
遞延所得稅 | 30.615 | 59.095 | 64.598 | 32.937 | |
Preferred Stock - Non Redeemable, Net | 0 | 0 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
流動資産總額 | 253.994 | 276.711 | 328.195 | 263.601 | 220.432 |
現金和短期投資 | 190.502 | 219.041 | 282.665 | 211.87 | 121.407 |
現金等價物 | 19.275 | 28.445 | 88.728 | 45.006 | 4.116 |
短期投資 | 171.227 | 190.596 | 193.937 | 166.864 | 117.291 |
應收賬款總額,淨額 | 36.003 | 27.994 | 29.188 | 35.038 | 65.953 |
應收賬款 - 貿易,淨額 | 36.003 | 27.994 | 29.188 | 30.424 | 65.168 |
總庫存 | 25.392 | 26.906 | 14.011 | 13.294 | 22.326 |
其他流動資産,總計 | 2.097 | 2.77 | 2.331 | 3.399 | 10.746 |
總資産 | 769.226 | 758.105 | 811.076 | 762.668 | 1050.6 |
物業/廠房/設備,總計 - 淨額 | 25.979 | 26.536 | 27.352 | 27.491 | 79.97 |
商譽,淨額 | 103.77 | 105.673 | 105.673 | 105.673 | 181.206 |
無形資産,淨額 | 321.445 | 336.16 | 344.347 | 352.637 | 527.218 |
其他長期資産,總計 | 16.956 | 13.025 | 5.509 | 13.266 | 41.779 |
流動負債總額 | 15.727 | 29.388 | 98.929 | 98.81 | 135.241 |
應付賬款 | 2.475 | 9.582 | 6.135 | 5.307 | 15.887 |
預提費用 | 10.511 | 7.35 | 15.637 | 16.351 | 21.683 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
長期債務的當前部分/資本租賃 | 0 | 0 | 76.833 | 76.74 | 76.648 |
其他流動負債,總計 | 2.741 | 12.456 | 0.324 | 0.412 | 21.023 |
負債總額 | 101.33 | 93.213 | 164.759 | 165.183 | 234.307 |
長期債務總額 | 0 | 0 | 0 | 0 | 0 |
長期債務 | 0 | 0 | |||
遞延所得稅 | 32.586 | 27.665 | 30.01 | 30.615 | 29.832 |
其他負債,總計 | 53.017 | 36.16 | 35.82 | 35.758 | 69.234 |
股權 | 667.896 | 664.892 | 646.317 | 597.485 | 816.298 |
普通股 | 0.018 | 0.017 | 0.017 | 0.017 | 0.017 |
額外實收資本 | 183.994 | 170.741 | 154.424 | 147.59 | 348.994 |
留存收益(累計赤字) | 484.828 | 495.101 | 492.811 | 450.862 | 468.347 |
其他權益,總計 | -0.944 | -0.967 | -0.935 | -0.984 | -1.06 |
總負債和股東權益 | 769.226 | 758.105 | 811.076 | 762.668 | 1050.6 |
已發行普通股總數 | 17.421 | 17.352 | 17.134 | 16.951 | 16.894 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 |
長期投資 | 47.082 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
淨收入/起跑線 | -33.361 | 57.138 | -2.985 | 629.302 | 143.321 |
經營活動産生的現金 | 137.85 | 78.798 | 54.586 | -29.336 | 194.059 |
經營活動産生的現金 | 51.534 | 51.071 | 25.691 | 18.361 | 14.718 |
Deferred Taxes | 20.723 | -8.618 | -19.053 | 74.829 | 29.739 |
非現金物品 | 33.277 | 31.371 | 60.997 | -747.613 | 48.066 |
Cash Taxes Paid | 11.642 | 3.722 | 2.13 | 103.817 | 0.341 |
已付現金利息 | 1.428 | 3.028 | 4.463 | 5.827 | 1.513 |
營運資金的變化 | 65.677 | -52.164 | -10.064 | -4.215 | -41.785 |
投資活動産生的現金 | 163.624 | 30.523 | 231.648 | 466.918 | -423.269 |
資本支出 | -17.923 | -8.761 | -4.458 | -2.553 | -10.887 |
其他投資現金流量項目,總計 | 181.547 | 39.284 | 236.106 | 469.471 | -412.382 |
融資活動産生的現金 | -275.99 | -137.761 | -310.545 | -485.172 | 328.585 |
融資現金流項目 | -18.219 | 11.87 | -3.806 | -7.418 | -160.962 |
股票的發行(報廢),淨額 | 3.232 | 15.317 | -74.981 | -450.431 | -42.779 |
債務的發行(退還),淨額 | -261.003 | -164.948 | -231.758 | -27.323 | 532.326 |
外彙效應 | 0 | 0 | 0.083 | -0.215 | |
現金淨變化 | 25.484 | -28.44 | -24.311 | -47.507 | 99.16 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | 41.949 | -33.361 | -15.876 | -16.28 | -15.385 |
Cash From Operating Activities | 33.948 | 137.85 | 84.378 | 63.889 | 52.011 |
Cash From Operating Activities | 9.499 | 51.534 | 40.399 | 26.921 | 13.655 |
Deferred Taxes | 8.754 | 20.723 | -25.57 | -12.925 | -16.18 |
Non-Cash Items | -34.151 | 33.277 | 46.32 | 32.079 | 19.64 |
Cash Interest Paid | 0 | 1.428 | 1.139 | 1.038 | 0.359 |
Changes in Working Capital | 7.897 | 65.677 | 39.105 | 34.094 | 50.281 |
Cash From Investing Activities | 10.549 | 163.624 | 170.908 | 151.732 | 113.881 |
Other Investing Cash Flow Items, Total | 12.963 | 181.547 | 186.7 | 163.195 | 118.756 |
Cash From Financing Activities | -0.775 | -275.99 | -270.692 | -229.863 | -170.421 |
Financing Cash Flow Items | -4.155 | -18.219 | -11.532 | -7.544 | -7.278 |
Issuance (Retirement) of Stock, Net | 3.393 | 3.232 | 1.831 | 1.011 | 0.347 |
Issuance (Retirement) of Debt, Net | -0.013 | -261.003 | -260.991 | -223.33 | -163.49 |
Foreign Exchange Effects | |||||
Net Change in Cash | 43.722 | 25.484 | -15.406 | -14.242 | -4.529 |
Cash Taxes Paid | 11.642 | 6.63 | 0.02 | 0 | |
Capital Expenditures | -2.414 | -17.923 | -15.792 | -11.463 | -4.875 |
差價合約交易計算器
計算您的假設損益
交易佣金
0
- 1:1
槓桿
1:1
- 20
- 100
- 500
- 1000
- 10000
交易
交易規模(槓桿 x 投資):
打開
拋售
已賣出 做多
Industry: | Pharmaceuticals (NEC) |
3911 Sorrento Valley Blvd
Suite 110
SAN DIEGO
CALIFORNIA 92121
US
盈虧控制
- Annual
- Quarterly
人們也觀看
還在尋找值得信賴的經紀商?
加入全球 610,000 多名交易者,選擇與 Capital.com 交易